L707-0603 Screening compound: N-benzyl-2-[2-oxo-7-(piperidine-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide

L707-0603 Screening compound: N-benzyl-2-[2-oxo-7-(piperidine-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
L707-0603 Screening compound: N-benzyl-2-[2-oxo-7-(piperidine-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L707-0603
N-benzyl-2-[2-oxo-7-(piperidine-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L707-0603

Molecular Formula

C24H29N3O4S (C24 H29 N3 O4 S)

Compound Name

N-benzyl-2-[2-oxo-7-(piperidine-1-sulfonyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide

IUPAC name

N-benzyl-2-[2-oxo-7-(piperidine-1-sulfonyl)-2345-tetrahydro-1H-1-benzazepin-1-yl]acetamide

SMILES

O=C(CN(c(cc1)c(CCC2)cc1S(N1CCCCC1)(=O)=O)C2=O)NCc1ccccc1

InChI

InChI=1S/C24H29N3O4S/c28-23(25-17-19-8-3-1-4-9-19)18-27-22-13-12-21(16-20(22)10-7-11-24(27)29)32(30,31)26-14-5-2-6-15-26/h1,3-4,8-9,12-13,16H,2,5-7,10-11,14-15,17-18H2,(H,25,28)

InChI Key

HUIZNJRARRBEIC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27471985

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.239

Distribution Coefficient, logD

3.239

Water Solubility, LogSw

-3.61

Polar Surface Area

72.132

Acid Dissociation Constant (pKa)

13.00

Base Dissociation Constant (pKb)

-1.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

L707-0603 in Drug Discovery

Included in Screening Libraries

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L707-0603 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L707-0603?
Check Price and Availability of L707-0603, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L707-0603 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L707-0603
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L707-0603
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L707-0603 available by request